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Patients with epilepsy are at high risk for major depression relative to the general population, and both disorders are associated with
changes in adult hippocampal neurogenesis, although the mechanisms underlying disease onset remain unknown. The expression of fosB,
an immediate early gene encoding FosB and DFosB/D2DFosB by alternative splicing and translation initiation, is known to be induced in
neural progenitor cells within the subventricular zone of the lateral ventricles and subgranular zone of the hippocampus, following
transient forebrain ischemia in the rat brain. Moreover, adenovirus-mediated expression of fosB gene products can promote neural stem
cell proliferation. We recently found that fosB-null mice show increased depressive behavior, suggesting impaired neurogenesis in fosB-
null mice. In the current study, we analyzed neurogenesis in the hippocampal dentate gyrus of fosB-null and fosBd/d mice that express
DFosB/D2DFosB but not FosB, in comparison with wild-type mice, alongside neuropathology, behaviors, and gene expression profiles.
fosB-null but not fosBd/d mice displayed impaired neurogenesis in the adult hippocampus and spontaneous epilepsy. Microarray analysis
revealed that genes related to neurogenesis, depression, and epilepsy were altered in the hippocampus of fosB-null mice. Thus, we
conclude that the fosB-null mouse is the first animal model to provide a genetic and molecular basis for the comorbidity between
depression and epilepsy with abnormal neurogenesis, all of which are caused by loss of a single gene, fosB.
Neuropsychopharmacology (2013) 38, 895–906; doi:10.1038/npp.2012.260; published online 16 January 2013
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INTRODUCTION
Neurological and psychiatric disorders are highly prevalent
in the general population. It has been shown that patients
with epilepsy are at high risk for major depression relative
to the general population, with the incidence of depression
being 5–20 times higher, but it is very often unrecognized
and untreated (Danzer, 2012). Decreased neurogenesis in
the adult hippocampus has been implicated in the
pathogenesis of anxiety and depression (Snyder et al,
2011). In addition, adult hippocampal neurogenesis is
known to be required for mediating the behavioral effects
of antidepressants and electroconvulsive therapy (ECT)
(Danzer, 2012).
In the adult rodent hippocampus, neurogenesis and
expression of fosB (Fosb), an immediate early gene are
increased by seizures induced by chemoconvulsants, such
as kainic acid (KA), electroconvulsive seizures (ECS), an
animal model of ECT, and forebrain ischemia. Among fos
family genes, only the fosB gene produces multiple protein
products, namely FosB, DFosB, and D2DFosB, by alternative
splicing and translation initiation (Chen et al, 1997;
Kurushima et al, 2005; Mandelzys et al, 1997; Morris et al,
2000; Nakabeppu and Nathans, 1991; Ohnishi et al, 2008;
Ohnishi et al, 2011; Sabatakos et al, 2008). DFosB is
a translation product of DfosB mRNA generated by
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alternative splicing, and lacks the C-terminal 101 amino
acids containing the transactivation domain in the full-
length FosB protein (Nakabeppu and Nathans, 1991).
D2DFosB is an N-terminally truncated isoform of DFosB,
which arises as a consequence of alternative initiation
of translation from Met79 of the DfosB mRNA and lacks
the N-terminal Fos homology domain as well as the
C-terminal transactivation domain (Sabatakos et al, 2008).
FosB and DFosB act in opposition to regulate Jun
transactivity, and also regulate cell proliferation, differen-
tiation, and cell death (Kurushima et al, 2005; Nakabeppu
et al, 1993; Tahara et al, 2003). DFosB, but not D2DFosB,
itself can act as a transcriptional activator or repressor
(McClung and Nestler, 2003; Renthal et al, 2008; Sabatakos
et al, 2008).
We recently reported that fosB-null mice exhibit depres-
sive-like behaviors, including decreased locomotion,
increased immobility during forced swimming, and
increased anxiety-like responses (Ohnishi et al, 2011).
Interestingly, fosBd/d mice, expressing fosBd alleles coding
only the DFosB and D2DFosB proteins, did not show
depressive-like behaviors, indicating DFosB/D2DFosB can
in part suppress the appearance of depressive-like beha-
viors. We have also observed that following transient
forebrain ischemia in the rat brain, expression of DFosB,
and to a lesser extent FosB, is induced in neural progenitor
cells within the subventricular zone of the lateral ventricles
and subgranular zone (SGZ) of the hippocampal dentate
gyrus (DG). Furthermore, adenovirus-mediated expression
of DFosB, and to a lesser extent FosB, promoted neural
stem cell proliferation, whereas inhibition of FosB
and DFosB expression caused neuronal differentiation
in rat embryonic cortical cell cultures (Kurushima et al,
2005).
Based on these findings, we hypothesized that the fosB
products, FosB, DFosB, and/or D2DFosB, promote basal and
injury-induced neurogenesis in the adult hippocampus, and
are involved in depression and epilepsy. To test our
hypothesis, we analyzed neurogenesis in the hippocampal
DG, as well as neuropathology and behaviors, of fosB-
null and fosBd/d mice. We show that fosB-null mice
exhibit impaired neurogenesis and spontaneous epilepsy,
in addition to depressive-like behaviors, while fosBd/d mice
do not.
MATERIALS AND METHODS
Animals
fosBþ /d mice with a mutant fosBd allele encoding DFosB and
D2DFosB but not FosB, and fosBþ /G mice with a null-mutant
allele, fosBG, were established. Heterozygous (fosBþ /d and
fosBþ /G) mice were backcrossed onto C57BL/6J males
(Clea Japan, Tokyo, Japan) and at least one time onto
C57BL/6J females for maintenance of the strains (Ohnishi
et al, 2011). To yield homozygous mutant mice, fosBd/d and
fosB-null (fosBG/G), fosBþ /d (N17 generation), or fosBþ /G
(N12 generation) mice were intercrossed. Homozygous
fosBd/d and fosB-null (fosBG/G) mutant mice lines were
maintained by inbreeding. Third and fourth generations
were used in the present study. C57BL/6J mice were used as
wild-type controls for all experiments. Genotyping of the
mutant alleles and animal housing conditions are provided
in Supplementary Materials and Methods.
KA Treatment
Eight- to Ten-week-old male mice were used in this study.
Mice were injected intraperitoneally with either saline
(untreated control) or 25mg/kg KA (Wako, Osaka, Japan).
They were then injected twice daily for 3 days with 50mg/kg
BrdU (Sigma-Aldrich Japan, Tokyo, Japan). To determine
the intensity of epileptiform seizures, we observed mice 2 h
after KA administration and scored the seizure according
to previously described criteria (Kajitani et al, 2006;
Supplementary Materials and Methods). Animals were
killed 1 day after the last BrdU injection, unless otherwise
stated.
Antibodies
All antibodies used in the present study are described in
Supplementary Materials and Methods.
Tissue Processing and Immunohistochemistry
Brain tissues were prepared and serial coronal sections
(40 mm) were cut on a cryostat and collected as free-floating
sections. The floating sections were subjected to immuno-
histochemistry. Detailed methods for tissue processing and
immunohistochemistry are in Supplementary Materials and
Methods.
Western Blotting
Nuclear extracts were prepared and subjected to western
blotting (Supplementary Materials and Methods).
Laser Scanning Confocal Immunofluorescence
Microscopy
Free-floating sections were subjected to immunofluores-
cence microscopy as described in Supplementary Materials
and Methods. Confocal images were acquired using an
LSM510 META Confocal Microscope System (Carl Zeiss
Microimaging Japan, Tokyo, Japan). All sections from each
experimental animal, and groups to be compared, were
processed in parallel.
Counting BrdU-Positive Cells
Free-floating sections were subjected to BrdU immunode-
tection, and the density of BrdU-positive cells in the granule
cell layer (GCL) or hilus of the DG was determined using the
fractionator program of the Stereo Investigator system
(MBF Bioscience, Williston, VT) (Supplementary Materials
and Methods).
Observation of Spontaneous Seizures
We observed behavioral seizure activity in animals during
cage changing for B20–30min per week, and scored
them as described previously (Kajitani et al, 2006). We
only scored stage 3–5 seizures as seizure episodes, as
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stage 1–2 seizures were hard to distinguish from normal
behavior.
Recording of Electroencephalogram Discharges for
Spontaneous Seizures
To investigate spontaneous electrical seizures using
electroencephalogram (EEG) recordings, mice were grouped
as follows: clinical seizures observed, fosB-null mice; clinical
seizures not observed, fosB-null mice; fosBd/d mice and wild-
type mice. Recording electrodes for EEG monitoring were
placed on the cerebral cortices and hippocampi of mice.
The protocol was identical for all three groups
(Supplementary Materials and Methods).
Microarray Hybridization and Data Analysis
Total RNA from the hippocampi of wild-type, fosBd/d, and
fosB-null mice was prepared using ISOGEN (Nippon Gene,
Tokyo, Japan) and the RNeasy Mini Kit (Qiagen, Tokyo,
Japan). For DNA microarray experiments, total RNA
(100 ng) was added to poly-A control and treated using
the WT Expression Kit (Ambion, Austin, TX, USA),
according to manufacturer’s instructions. cDNA was labeled
using the WT terminal labeling kit (Affymetrix Japan,
Tokyo, Japan) and hybridized against the GeneChip Mouse
Gene 1.0 ST array (Affymetrix). The resulting list of
expressed probes was imported into GeneSpring GX 10.0
(Agilent Technologies, Palo Alto, CA, USA) for data
analysis. The microarray data discussed in this publication
have been deposited in the NCBI’s Gene Expression
Omnibus and are accessible through GEO Series accession
number, GSE37056.
Real-Time RT–PCR Analysis
Total RNA was prepared from the hippocampus of mice
using ISOGEN. First-strand cDNA was synthesized using
the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems Japan, Tokyo, Japan), according to
manufacturer’s instructions. For quantitative real-time
RT–PCR of Vgf, Smad3, Galanin, Trh, and Sema3e mRNA,
reactions were performed in triplicate as described in
Supplementary Materials and Methods.
Statistical Analysis
Stereological counts were compared by analysis of variance
(ANOVA), by fitting a linear model by least squares,
followed by Tukey’s honestly significant difference (HSD)
test. Microarray data were compared using unpaired t-tests
or two-way ANOVA. The p-values were adjusted for false
discovery using the Benjamini-Hochberg procedure
(Benjamini and Hochberg, 1995). The rest of the data were
compared using the Kaplan–Meier method and log-rank
tests, or Fisher’s exact test as indicated. A value of po0.05
was considered as statistically significant. Except
for microarray analysis data, all statistical analyses were
carried out using JMP 9.02 software (SAS Institute, Cary,
NC, USA).
RESULTS
Induced Expression of fosB Products in Activated
Neural Progenitors, Immature-Newborn and Mature
Neurons in the DG After KA Treatment
Western blotting analysis of hippocampal nuclear extracts
using anti-FosB (5G4), which recognizes all fosB products
(FosB, DFosB, and D2DFosB), detected a 43-kDa polypep-
tide, representing the full-length FosB protein, in wild-type
mice only. While 32/36-kDa and 24-kDa polypeptides,
representing DFosB and D2DFosB proteins respectively,
were detected in wild-type and fosBd/d mice (Figure 1a). No
fosB products were detected in fosB-null mice.
Basal levels of DFosB and D2DFosB proteins were
marginally higher in fosBd/d compared with wild-type mice.
Six hours after KA administration, there was a transient
increase in FosB levels in wild-type mice. Levels of DFosB
and D2DFosB were stably increased within 24 h after KA
administration in both wild-type and fosBd/d mice
(Supplementary Figure S1a).
Immunohistochemistry using anti-FosB (N) or anti-
FosB(5G4) in untreated wild-type hippocampus detected
sparse expression of fosB products in most hippocampal
neurons. Levels of fosB products were increased after KA
administration (Figure 1b; Supplementary Figure S1b). In
wild-type mice, immunoreactivity (IR) in DG granule
neurons was highest among all subregions of the hippo-
campus, and maximal 6 h after KA administration
(Figure 1b; Supplementary Figures S1b–d). A similar
increase was observed in the hippocampus from fosBd/d
mice, 6–24 h after KA administration. No anti-FosB (N) IR
was detected in fosB-null hippocampus (Figure 1b).
To distinguish expression of FosB and DFosB/D2DFosB
in wild-type hippocampus, we performed laser scanning
confocal immunofluorescence microscopy (LSCIM), using
three different antibodies against fosB products, anti-FosB
(5G4), anti-FosB (C), and anti-DFosB. The latter two
antibodies recognize FosB and DFosB/D2DFosB, respec-
tively (Figure 1c). Anti-FosB (C) IR was barely detectable in
untreated hippocampus, and was transiently detected in the
hippocampus 6 h after KA administration. Seventy-two
hours after KA administration, anti-FosB (C) IR had
returned to basal levels. Conversely, anti-DFosB IR was
strongly detected in most neurons from untreated hippo-
campus, with significantly increased levels observed in
hippocampal neurons from 6 to 72 h after KA administra-
tion. Moreover, we found that a number of anti-FosB (C)
and anti-DFosB IR-positive cells, detected in the SGZ of DG
6 h after KA administration, were SOX2 positive, suggesting
that expression of both FosB and DFosB/D2DFosB
was transiently induced in neural progenitor cells (Lugert
et al, 2010).
Strong anti-FosB (5G4) IR was detected in the majority of
NeuN-positive neurons throughout the hippocampus, 72 h
after KA administration (Supplementary Figure S2), sug-
gesting that increased expression of DFosB/D2DFosB is
chronically maintained in most hippocampal neurons after
KA administration. After KA administration, anti-FosB
(5G4) IR was detected in a few star-shaped glial fibrillary
acidic protein (GFAP)-positive astrocytes in the DG hilus
(arrowheads in Supplementary Figure S3, left panels), but
not in radial glia-like GFAP-positive cells, that have a radial
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process spanning the entire GCL and ramify in the inner
molecular layer of the DG. Anti-FosB (5G4) IR was not
observed in Ki67-positive proliferating cells detected in the
SGZ, with or without KA administration (Supplementary
Figure S3, middle). A proportion of doublecortin (DCX)-
positive cells with axon-like processes in the GCL,
representing immature newborn neurons (Lugert et al,
2010), exhibited relatively weak anti-FosB (5G4) IR 72 h
after KA administration (arrows in Supplementary Figure
S3, right panels).
Overall, our results show that excitotoxicity transiently
induces FosB expression in SOX2-positive/non-proliferating
neural progenitors in the DG, as well as in mature neurons of
the hippocampus. Moreover, expression of DFosB/D2DFosB
is transiently induced in SOX2-positive neural progenitors,
but chronically in mature hippocampal neurons, and to a
Figure 1 Wild-type, fosBd/d, and fosB-null mice showed differential expression of FosB, DFosB, and D2DFosB in the hippocampus. (a) Western blotting of
fosB products in hippocampal nuclear extracts. Nuclear extracts (12.5 mg protein per lane) were prepared from hippocampi at indicated times after saline
(C) or KA (6 h, 24 h) administration, and were subjected to western blotting with anti-FosB (5G4) (upper panel). fosB products are highlighted: black arrow
(FosB), open arrowheads (DFosB), and closed arrowhead (D2DFosB). Blots were post-stained with Ponceau S (lower panel). Quantified results are shown in
Supplementary Figure S1a. (b) Immunohistochemistry of fosB products at 0 h (control), 6 h, or 24 h after KA administration in the adult hippocampus of wild-
type, fosBd/d, and fosB-null mice. Anti-FosB (N) was used to detect fosB products (FosB, DFosB, and D2DFosB). Scale bar: 500 mm. (c) Laser scanning confocal
immunofluorescence microscopy of fosB products at 0 h (control), 6 h, or 72 h after KA administration in the DG of wild-type mice. Three different
antibodies against fosB products, anti-FosB (5G4), anti-FosB (C), and anti-DFosB were used to detect fosB products (red). SOX2 protein (green), a marker
for neural progenitor cells, was dominantly detected in SGZ of the DG. Arrows indicate cells expressing both fosB products and SOX2. Orthogonal
projections throughout the cells are shown. Scale bars: 50 mm. Percentage of anti-FosB IR-positive cells in the SOX2-positive population is shown in
parentheses with SEM. More than 100 SOX2-positive cells in each animal (N¼ 3) were observed. *p¼ 0.0421 (anti-FosB (C) IR vs anti-DFosB IR-positive
population 6 h after KA administration, Fisher’s exact test).
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lesser extent in immature newborn neurons of the DG
(Supplementary Figure S4).
fosB-Null Mice Show Decreased Proliferation and
Increased Ectopic Migration of Neural Progenitor Cells
in the Adult Hippocampus
To determine if fosB products affect proliferation of neural
progenitor cells in the adult hippocampus, we injected BrdU
twice daily for 3 days in wild-type, fosBd/d, and fosB-null
mice, following KA or saline injection. Brain sections were
prepared 1 day later (Figure 2a). BrdU-positive cells were
predominantly distributed in the SGZ (Figure 2b). To
confirm that BrdU-positive cells represented newborn
neurons, LSCIM was performed using antibodies against
BrdU, DCX, and NeuN (Figure 2c; Supplementary Figure
S5). Irrespective of KA administration or genotype, 470%
of BrdU-positive cells in the DG expressed both DCX and
NeuN (Figure 2d and e). The remainder of BrdU-positive
cells expressed either DCX or NeuN. Thus, the majority of
BrdU-positive cells detected (Figure 2b) represented new-
born neurons in the DG.
Next, we estimated the density of BrdU-positive cells in the
DG using stereological counting methods (Figure 2f). The
density of BrdU-positive cells in controls, without KA
administration, was significantly decreased in fosB-null
compared with wild-type mice (p¼ 0.0066, Tukey–Kramer
HSD post hoc comparison), while there was a slight, albeit
non-significant, increase in fosBd/d mice (Figure 2f, left). In all
three genotypes, KA administration significantly increased
the density of BrdU-positive cells in comparison with each
untreated control (wild type, p¼ 0.0006; fosBd/d, p¼ 0.0006;
fosB-null, p¼ 0.0015, t-test). The density of BrdU-positive
cells in fosB-null mice, after KA administration, was
significantly lower compared with wild-type mice (p¼ 0.002,
Tukey–Kramer HSD post hoc comparison) (Figure 2f, right).
LSCIM identified the majority of BrdU-positive cells in the
hilus as newborn neurons, expressing DCX and NeuN, either
individually or in combination (Figure 3a). We compared the
density of BrdU-positive cells in the hilus, and found that
without KA administration, fosB-null mice had a slightly
higher density of BrdU-positive cells compared with wild-
type and fosBd/d mice. Following KA administration, the
density of BrdU-positive cells in both fosBd/d and fosB-null
mice was increased slightly, but to a lesser extent compared
with wild-type mice (Figure 3b). The percentage of BrdU-
positive cells in the hilus (calculated from the total number of
BrdU-positive cells in the whole DG) was highest in fosB-null
and lowest in fosBd/d mice, regardless of KA administration,
suggesting that newborn neurons in fosB-null, but not fosBd/d
mice, show increased migration into the hilus in comparison
with wild type (Figure 3c).
We next examined survival of newborn neurons in the
DG. BrdU was injected into wild-type and fosB-null mice
twice daily for 3 days, following saline administration
(Supplementary Figure S6a). The density of BrdU-positive
cells in the DG was determined 1 day and 70 days after the
last BrdU injection. There was no significant difference in
the survival of BrdU-positive cells in the DG after 70 days
(wild type: 19.47±3.50%; fosB-null: 14.85±0.66%)
(Supplementary Figure S6b). In both mouse lines, all
BrdU-positive cells were NeuN positive and were detected
in the GCL/SGZ and hilus (Supplementary Figure S6c),
suggesting that fosB products do not affect survival and
maturation of newborn neurons.
We compared seizure scores and hippocampal damage in
wild-type, fosBd/d, and fosB-null mice after KA administra-
tion. We found no significant difference in both seizure
response 2 h after KA administration and hippocampal
damage 6 days after KA administration, among the three
mouse lines (Supplementary Figure S7).
fosB-Null Mice Display Spontaneous Epilepsy
fosB-null mice occasionally exhibited spontaneous seizures,
often associated with behavioral arrest and forelimb clonus
(Supplementary video S1). Seizures were observed from
13 weeks of age and the non-incidence rate of seizures
decreased as age increased. Approximately, 80% of fosB-
null mice exhibited spontaneous seizures by 80 weeks
(Figure 4a). The seizures were similar to KA-induced
seizures that are widely accepted as a model of temporal
lobe epilepsy (Ben-Ari and Cossart, 2000). Neither wild-type
nor fosBd/d mice displayed seizures.
To confirm electrophysiological changes of epilepsy
in fosB-null mice, EEG recordings were performed using
50- to 70-week-old wild-type, fosBd/d, and fosB-null mice
(Supplementary Figure S8; Figure 4b). Wild-type and fosBd/d
mice displayed low baseline amplitude throughout the
observation period (upper and middle panels in Figure 4b).
However, in fosB-null mice, typical spontaneous electro-
graphic seizures were observed, with the onset of epilepti-
form discharge from the hippocampus and secondary
generalization to the cortex (bottom panel in Figure 4b).
Spontaneous epileptiform EEG activity was verified in
27.3% of fosB-null mice examined. The spontaneous
seizures had durations of up to 47 s. The majority of
recorded seizures were strong, with generalized tonic-clonic
episodes that occurred in the hippocampus and spread to
the cortex. We concluded that fosB-null mice display
hippocampal-onset epileptic seizures with secondary gen-
eralization to tonic-clonic convulsions.
An abnormal hippocampal cell arrangement including
thinning of the GCL of the DG was characteristic of fosB-
null mice regardless of behavioral seizures (Figure 4c).
Neither wild-type nor fosBd/d mice showed any histological
abnormalities. We also examined the density of parvalbu-
min-positive interneurons in the DG, and found that the
density was slightly decreased in both fosBd/d and fosB-null
mice compared with wild-type mice, albeit non-significantly
(Supplementary Figure S9). Thus, our results indicate
that expression of DFosB and/or D2DFosB is sufficient
to suppress spontaneous epilepsy, as determined by an
absence of spontaneous seizures, epileptic EEGs, and
abnormal DG structures in the adult brain of wild-type
and fosBd/d mice.
fosB Products Regulate Expression of Various Genes
Involved in Neurogenesis, Depression, Migration,
and Epilepsy
To examine fosB regulation of neurogenesis, depression,
and epilepsy, we compared the gene expression profiles of
wild-type, fosBd/d, and fosB-null mice. Total RNA was
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Figure 2 Adult fosB-null mice show reduced basal and KA-induced proliferation of neural progenitor cells in the hippocampus. (a) Experimental design.
For 3 days following saline (control) or KA injection, mice were injected with BrdU twice daily. Brain sections were prepared on the 6th day, and
BrdU-positive cells were detected. (b) Immunohistochemistry for BrdU in adult DG of wild-type, fosBd/d, and fosB-null mice, following saline (control) or KA
injection. Scale bar: 200 mm. (c) Laser scanning confocal immunofluorescence microscopy for DCX (green) and NeuN (blue), both neuronal lineage markers,
and BrdU (red). Scale bar: 50mm. (d) Phenotype of BrdU-positive cells in the DG. Orthogonal projections throughout the cells are shown to demonstrate
triple (BrdUþ /DCXþ /NeuNþ shown with white arrowheads) and double-labeled (BrdUþ /NeuNþ shown with magenta arrowheads) cells. BrdUþ
single-labeled or BrdUþ /DCXþ double-labeled cells are not seen in this panel. Scale bar: 50mm. (e) fosB products do not affect differentiation of newborn
neurons. One hundred BrdU-positive cells, within immunofluorescence-stained sections from each animal, and two animals for each group, were examined
by confocal microscopy to determine the phenotype of BrdU-positive cells. In all three genotypes, the majority of BrdU-positive cells express DCX and/or
NeuN. Bar graphs show percentages of BrdUþ /DCX /NeuN (black), BrdUþ /DCX /NeuNþ (gray), BrdUþ /DCXþ /NeuN (hatched), and
BrdUþ /DCXþ /NeuNþ (open) cells. (f) Density of BrdU-positive cells in the DG was determined. N¼ 5 in each group; error bars, mean±SEM; black
bars, wild type; gray bars, fosBd/d; open bars, fosB-null. One-way ANOVA (control, F2,12¼ 9.56, p¼ 0.0033; KA, F2,12¼ 10.08, p¼ 0.0027). The p-values
(Tukey–Kramer HSD post hoc comparison) are shown.
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isolated from hippocampi of wild-type, fosBd/d, and fosB-
null mice 24 h after administration of saline or KA, and
subjected to microarray analysis.
Expression levels of 63 genes were significantly altered in
fosB-null mice compared with wild-type and/or fosBd/d
mice, with or without KA administration (Supplementary
Table S1). In young saline controls, 23 genes were
significantly downregulated and one gene significantly
upregulated in fosB-null mice compared with fosBd/d or
wild-type mice. Twenty-four hours after KA administration
in young mice, 29 genes were significantly downregulated
and 12 genes significantly upregulated in fosB-null mice
compared with fosBd/d or wild-type mice. In aged untreated
mice, expression of two genes was significantly higher in
fosB-null mice compared with wild-type mice. Expression
levels of Vgf, Smad3, Gal, Trh, and Sema3e were confirmed
by quantitative RT–PCR analysis (Supplementary Table S2;
Supplementary Figure S10).
Our results indicate that fosB differentially regulates
expression of a number of genes, particularly following KA
administration. Among them, 10 genes (Vgf, Dlk1, Smad3,
Gal, Trh, Islr2, Penk, Srxn1, Serinc2, and Car12; Table 1) are
likely to be involved in neurogenesis, depression, migration,
or epilepsy, as discussed later. Among the 10 genes, Vgf,
Gal, Trh, Penk, Srxn1, and Smad3 are known to be regulated
by the activator protein-1 (AP-1) complex. Vgf, Gal, Trh,
Penk, and Srxn1 have AP-1 sites in their promoter regions,
whereas SMAD3 interacts with AP-1 complexes (FOS, JUN,
and JUNB), to regulate TGF-b signaling (Zhang et al, 1998;
Table 1; Supplementary Figure S11).
DISCUSSION
fosB-Null Mice Display Impaired Neurogenesis in the
Adult Hippocampus, Increased Depressive-like
Behaviors and Spontaneous Epilepsy
In the current study, we have shown that fosB-null mice
exhibit decreased proliferation of neuronal progenitor
cells, increased ectopic migration of newborn neurons
during basal and KA-induced neurogenesis in the adult
hippocampus, and adult-onset spontaneous epileptic
seizures, epileptic EEGs, and abnormal hippocampal
structures. Conversely, compared with wild-type mice,
fosBd/d mice exhibited a similar level of basal proliferation
of neuronal progenitor cells, with decreased KA-induced
proliferation and decreased ectopic migration of newborn
neurons in the hippocampus, but importantly, fosBd/d mice
did not exhibit spontaneous seizures, epileptic EEGs, or
abnormal hippocampal structures.
In the present study, we compared various phenotypes of
fosBd/d and fosB-null mutant mice with those of C57BL/6J
mice as a wild-type strain, onto which the mutant mouse
lines were backcrossed 412 generations. However, a
Figure 3 Adult fosB-null mice show increased ectopic migration of
neural progenitor cells in the hippocampus. As shown in Figure 2a, for
3 days following saline (control) or KA injection, mice were injected
with BrdU twice daily. Brain sections were prepared on the sixth day, and
BrdU-positive cells were detected. (a) Laser scanning confocal immuno-
fluorescence microscopy for BrdU (red), DCX (green), and NeuN (blue) in
the hilus of fosB-null mice. The arrowheads indicate ectopic neuroblasts or
immature neurons (BrdUþ /DCXþ /NeuNþ ). Orthogonal projections
throughout the cells are shown. Scale bar: 50mm. (b) The density of BrdU-
positive cells in the hilus. N¼ 5 in each group; error bars, mean±SEM;
black bars, wild type; gray bars, fosBd/d; open bars, fosB-null. One-way
ANOVA (control: F2,12¼ 2.53, p¼ 0.121; KA: F2,12¼ 8.58, p¼ 0.0049). The
p-values (Tukey–Kramer HSD post hoc comparison) are shown. (c) The
percentage of BrdU-positive cells in the hilus, calculated from the total
number of BrdU-positive cells in the entire DG. N¼ 5 in each group; error
bars, mean±SEM; black bars, wild-type; gray bars, fosBd/d; open bars, fosB-
null. One-way ANOVA (control: F2,12¼ 14.53, p¼ 0.0006; KA:
F2,12¼ 20.17, p¼ 0.0001). The p-values (Tukey–Kramer HSD post hoc
comparison) are shown.
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considerable amount of allelic differences are still expected
near the mutated fosB locus on chromosome 7 between
C57BL/6J and mutant mice (Flaherty and Bolivar, 2007).
fosB-null mice exhibited largely different phenotypes in
comparison with C57BL/6J and fosBd/d mice, the latter two
exhibited rather similar phenotypes regarding spontaneous
epilepsy, depressive-like behaviors, and extent of adult
neurogenesis in the hippocampus, and these phenotypes
were maintained through the generations of backcross
(N¼ 4 to N¼ 12 or 17) (unpublished observation).
Although it remains possible that allelic differences in the
chromosome 7 modify the phenotypes, our results indicate
that the phenotypes reported here are determined by the
fosB locus, at least in part.
We previously found that fosB-null mice exhibit increased
depressive-like behaviors, whereas fosBþ /d mice, with
reduced expression of FosB and enhanced expression of
DFosB and D2DFosB, exhibit antidepressive-like behaviors
(Ohnishi et al, 2011). These data indicate that fosB products,
especially DFosB and/or D2DFosB, promote and maintain
intact neurogenesis in the adult hippocampus, and ensure
suppression of depression and spontaneous epilepsy. A
previous study demonstrated that repeated ECS induces
expression of fosB products in the prefrontal cortex and
tolerance to repeated ECS is significantly attenuated in fosB-
null mice (Hiroi et al, 1998). Taken together, the results
suggest that fosB products have multiple effects on various
aspects of seizures in multiple regions of the brain.
Figure 4 Aged fosB-null mice exhibit spontaneous seizures with epileptiform electroencephalograph discharges that originate in the hippocampus, and an
abnormal DG structure. (a) The non-incidence rate of spontaneous seizures. Wild-type and fosBd/d mice, N¼ 10; fosB-null mice, N¼ 40. *po0.0001,
Kaplan–Meier method and log-rank test (w2¼ 40.94, df¼ 2). (b) Concurrent hippocampal and cortical EEGs in 50- to 70-week wild-type (upper panel),
fosBd/d (middle panel), and fosB-null mice (lower panel). Lt cortex, left cortex; Rt cortex, right cortex; Lt hipp, left hippocampus; Rt hipp, right hippocampus.
N¼ 5 in each group. Scale bars: X axis, 4 s; Y axis, 0.5mV. (c) Nissl stained coronal hippocampal sections from wild-type, fosBd/d, and fosB-null mice.
Characteristic abnormal arrangements (arrows) and thinning (bidirectional arrow) of the GCL are observed in fosB-null mice regardless of seizures.
Seizure , without any seizures; Seizureþ , with seizures. Scale bar: 500 mm.
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Table 1 Candidate Genes for Neurogenesis, Depression, and Epilepsy Regulated by fosB Products
Fold change Literaturea
Untreated 24h after KA
Symbol Gene name null/wt dd/wt null/dd null/
wt
dd/
wt
null/dd AP-1 ECS Neurogenesis Depression Epilepsy or seizures
Young
Vgf VGF nerve growth factor inducible  1.29  1.42 1.23 Canu et al (1997) m Wang et al (2010) Thakker-Varia et al (2007) Thakker-Varia
et al (2007)
Newton et al (2003)
Dlk1 Delta-like 1 homolog (Drosophila) 1.22 Surmacz et al (2011)
Smad3 MAD homolog 3 (Drosophila)  1.67 Verrecchia et al (2001) Wang and Symes (2010)
Gal Galanin prepropeptide  2.30*  1.86 1.24 Anouar et al (1999) m Wang et al (2010) Abbosh et al (2011) Abbosh et al (2011) Mazarati et al (2000)
Trh Thyrotropin-releasing hormone  3.26*  2.50* 1.30 Cote-Velez et al (2005) m Wang et al (2010) Sattin et al (1994) Deng et al (2006)
Islr2 Immunoglobulin superfamily
containing leucine-rich repeat 2
 1.33 Pramparo et al (2011)
Penk Preproenkephalin 1  2.17*  1.51 1.44 Hyman et al (1988) Ogden et al (2004) Lason et al (1994)
Srxn1 Sulfiredoxin 1 homolog
(S. cerevisiae)
 1.21 Soriano et al (2008) Soriano et al (2008)
Serinc2 Serine incorporator 2 1.38 Inuzuka et al (2005)
Aged
Ca12 Carbonic anhydrase XII 2.21 ND ND ND Halmi et al (2006);
Winum et al (2009)
Among 63 genes altered in the hippocampus of fosB-null mice, 10 genes are related to neurogenesis, depression, or epilepsy. Fold changes (null/wt, fosB-null vs wt; dd/wt, fosBd/d vs wt; null/dd, fosB-null vs fosBd/d).
Numbers in bold indicate fold change41.2 oro 1.2, and po0.05 by unpaired t-test. Numbers with an asterisk indicate fold change42.0 oro 2.0, and po0.05 by ANOVA. p-value computation; Asymptotic Multiple
Testing Correction; Benjamini Hochberg FDR (Benjamini and Hochberg, 1995).
aLiterature columns indicate previous evidence for the following categories. AP-1: existence of AP-1 sites in the promoter regions or reported interactions with AP-1 transcription factors (þ ); ECS: evidence of
upregulation by ECS (m); NG: involvement in neurogenesis; DP: involvement in depression; E/S: seizure- or epilepsy-associated regulation. ND, not done.
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fosB Regulates Specific Genes to Maintain Intact
Neurogenesis and Suppress Spontaneous Epilepsy
Gene expression profiling suggests that expression of Vgf,
Gal, Trh, Penk, and Srxn1 is likely to be regulated by
FosB and to a lesser extent DFosB/D2DFosB. Among them,
Vgf and Gal are reported to be involved in both
neurogenesis and seizures or epilepsy (Abbosh et al, 2011;
Mazarati et al, 2000; Newton et al, 2003; Thakker-Varia
et al, 2007), and whose expression is likely to be upregulated
by both FosB and DFosB/D2DFosB (Supplementary Figure
S10). These results may explain why only fosB-null, but not
fosBd/d, mice exhibit spontaneous epilepsy together with a
severe decline in neurogenesis (Figures 2f and 4).
It is well known that GABAergic interneurons play
an important role in suppressing epilepsy (Perucca and
Mula, 2012). In this study, we found a slight decrease in
the density of parvalbumin-positive interneurons in both
fosBd/d and fosB-null DG, the latter only exhibiting spon-
taneous epilepsy (Supplementary Figure S9). However,
fosB-null mice exhibited the lowest expression of mRNA for
TRH, which promotes GABA release (Deng et al, 2006), after
KA administration, while fosBd/d mice exhibited the highest
TRH mRNA level in untreated conditions (Supplementary
Figure S10). This may also contribute to the spontaneous
epilepsy seen in fosB-null mice. It is noteworthy that the
level of Car12 mRNA encoding carbonic anhydrase 12 was
increased 42-fold only in aged fosB-null mice (Table 1).
Because topiramate 1, an inhibitor of carbonic anhydrases,
is a broad-spectrum anti-epileptic drug (Winum et al,
2009), it is likely that DFosB and/or D2DFosB as well as
FosB repress Car12 expression, thereby resulting in epilepsy
suppression.
DFosB and/or D2DFosB Maintain the Intact Structure
of Adult Hippocampus
fosB-null mice exhibited abnormalities in hippocampal
structures, which were similar to those observed in brains
of rodent models and human patients with epilepsy
(Fahrner et al, 2007). Undulation or thinning of the GCL
of the DG was observed in fosB-null mice, and may be due
to either a neuronal migration defect or decreased
hippocampal neurogenesis. Tyrosine kinase fyn-deficient
mice have previously been reported to have a similar
undulation of the DG (Grant et al, 1992), and also show
increased susceptibility to audiogenic seizures (Miyakawa
et al, 1995). fosBd/d mice did not show these structural
abnormalities, indicating that the presence of DFosB and/or
D2DFosB was sufficient to suppress them.
Among the 10 fosB-regulated genes, Islr2, which encodes
the immunoglobulin superfamily containing leucine-rich
repeat 2, is downregulated in mouse models of human
neuronal migration defects, and is also mutated in seizure
patients (Pramparo et al, 2011). SMAD3 and DLK1 are also
reported to be involved in cell migration (Wang and Symes,
2010; Yin et al, 2006). We previously reported that DFosB/
D2DFosB positively, whereas FosB negatively, regulates
cell–matrix adhesion and the TGF-b1 signaling pathway
in mouse embryonic stem cells (Ohnishi et al, 2008).
Moreover, E-cadherin, an important cell–cell adhesion
molecule, is an indirect target of fosB gene products in the
adult mouse striatum and hippocampus (Ohnishi et al,
2011), suggesting that fosB products indirectly regulate cell
migration and structural maintenance of the hippocampus.
fosB May Suppress Depressive-Like Behaviors Through
Regulation of Downstream Genes That Enhance
Neurogenesis
Recently, it was reported that adult-born hippocampal
granule neurons dynamically regulate stress reactivity
at both the endocrine and behavioral levels (Snyder et al,
2011). VGF and GAL exert antidepressant action by
enhancing neurogenesis in the hippocampus and/or
through other effects. Vgf is downregulated in animal
models of depression and human bipolar postmortem brain
(Thakker-Varia et al, 2010, 2007). GAL exhibits antidepres-
sant-like effects in human patients with depression (Murck
et al, 2004), which may be partly mediated by a direct
effect of GAL on hippocampal neurogenesis (Abbosh et al,
2011). Moreover, hippocampal TRH induction has also been
proposed to have antidepressant effects (Sattin et al, 1994).
Taken together, our present findings suggest that fosB
suppresses depressive-like behavior through upregulation
of these genes (Supplementary Figure S11).
fosB Targets May Act in an Autocrine/Paracrine Manner
Expression of fosB products was significantly increased
in mature hippocampal neurons, SOX2-positive/GFAP-
negative neural progenitor cells, and immature newborn
neurons in the DG after exposure to KA. Ki67-positive
proliferating cells did not express fosB products. Since
exogenous expression of FosB or DFosB in quiescent
fibroblasts and embryonic cortical cells induces their
proliferation (Kurushima et al, 2005; Nakabeppu et al,
1993), it is likely that brain stimuli such as KA treatment
or ischemic insults immediately and transiently induce fosB
expression in neural stem-like cells, thus stimulating their
own proliferation.
Of the genes listed in Table 1, 10 are expressed in
hippocampal neurons, as determined by in situ hybridiza-
tion (ISH) images (http://mouse.brain-map.org/) provided
by the Allen Institute for Brain Science. As VGF, TRH, GAL,
and PENK are secretary molecules, it is feasible that these
proteins are expressed and function within fosB-expressing
hippocampal neurons, but also act in an autocrine/
paracrine manner to regulate neighboring progenitor cells.
Conclusion
The present study demonstrates that the fosB-null mouse is
the first animal model to provide a genetic and molecular
basis for the comorbidity of epilepsy and depression with
abnormal neurogenesis, all of which are caused by loss of a
single gene, fosB. Since depression and epilepsy are known
to share a genetic basis (Hesdorffer et al, 2012), it will
be important in the future to determine if alterations in
the fosB gene, or its expression, are associated with these
disorders in humans. Identifying alterations will provide
insight into the diagnosis and treatment of these compli-
cated disorders.
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